You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

268 Results
Guidelines and Advice
Status: Current
Apr 2020
Guidelines and Advice
Status: Current
Oct 2019
Document
Oct 2020
Document
Feb 2021
Document
Feb 2021
Document
Mar 2021
Document
Mar 2021
Document
Mar 2021
Document
Mar 2021
Guidelines and Advice
Status: Current
ID: ES 30-1
Mar 2021
Document
Apr 2021
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    venetoclax - Treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) according to clinical criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
venetoclax
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
May 2024

Pages